An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.
Główni autorzy: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Wydane: |
2013
|
Streszczenie: |
---|